Sime Darby Oils, UKM plan liver treatment trials using palm oil extract


Sime Darby Oils MD Mohd Haris Mohd Arshad said: "The importance of developing partnerships with institutions such as the UKM is that it allows for both the development and practical implementation of our findings."

KUALA LUMPUR: Sime Darby Oils (SDO) and Universiti Kebangsaan Malaysia (UKM) will carry out clinical trials to find out if the palm oil derived Tocotrienols can be used in treating non-alcoholic fatty liver disease (NAFLD).

In a joint statement issued on Tuesday, they said this is the world’s first comprehensive clinical trial whether Tocotrienols, an antioxidant in the vitamin E family, could be used in NAFLD treatment.

Subscribe now and receive free sooka plan for 1 month. T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Nextgreen taps into Libyan fertiliser sector
Keyfield bags PETRONAS Carigali contract
DKSH 1Q25 net profit rises 19% on strong sales�
U Mobile exits DNB to drive second 5G network
Uzma unit secures electric wireline project
‘Good news’ for bourse
Nestcon wins RM44mil Labu project
Minimal impact from Trump’s drug pricing order
Peterlabs suspends director
Robust retail sales, tourist arrivals a boon to Malaysia

Others Also Read